Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Trends in Cell Biology|June 15, 2005
Centrosome control of the cell cycleStephen Doxsey, Wendy Zimmerman, Keith MikuleThe Journal of Biological Chemistry|April 1, 2003
Eicosanoid activation of protein kinase C epsilon: involvement in growth cone repellent signalingKeith Mikule, Somkiat Sunpaweravong, Jesse C Gatlin, et al.Nature Cell Biology|March 3, 2007
Loss of centrosome integrity induces p38-p53-p21-dependent G1-S arrestKeith Mikule, Benedicte Delaval, Philipp Kaldis, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 22, 2002
Growth cone collapse induced by semaphorin 3A requires 12/15-lipoxygenaseKeith Mikule, Jesse C Gatlin, Becky A de la Houssaye, et al.Cell Cycle (Georgetown, Tex.)|September 14, 2006
Selective induction of necrotic cell death in cancer cells by beta-lapachone through activation of DNA damage response pathwayXiangao Sun, Youzhi Li, Wei Li, et al.Oncotarget|January 17, 2019
A comparative pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor modelsKaiming Sun, Keith Mikule, Zebin Wang, et al.Cell Cycle (Georgetown, Tex.)|August 21, 2007
The IKK inhibitor BMS-345541 affects multiple mitotic cell cycle transitionsHana Blazkova, Conrad von Schubert, Keith Mikule, et al.British Journal of Cancer|November 15, 2018
Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenograftsÁdám Póti, Kinga Berta, Yonghong Xiao, et al.Proceedings of the National Academy of Sciences of the United States of America|January 22, 2015
Suppression of cancer relapse and metastasis by inhibiting cancer stemnessYouzhi Li, Harry A Rogoff, Sarah Keates, et al.Neuro-Oncology Advances|July 10, 2020
Efficacy and pharmacodynamics of niraparib in BRCA-mutant and wild-type intracranial triple-negative breast cancer murine modelsMaria J Sambade, Amanda E D Van Swearingen, Marni B McClure, et al.Pageof 2